CrossrefInfokarte
Predictors of early discontinuation and therapeutic response to anamorelin in patients with cancer cachexia: A retrospective study
Int. Journal of Clinical Pharmacology and Therapeutics · 2026-10-01 · 64 (10) · 526-536
DOI: 10.5414/cp204997 ↗Abstract
Kein Abstract verfügbar.
EUVIMED